Assessing Country Medicines Situations

Measuring Country Medicines Situations

For many years, DPM faculty members have provided technical assistance to the World Health Organization, the UK Department for International Development (DFID)-supported Medicines Transparency Alliance, the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, the Gates Foundation-funded Sustainable Drug Seller Initiatives (SDSI), and others in the development of standardized tools to measure important aspects of country pharmaceutical situations.

WHO pharmaceutical sector country profiles are a practical indicator-based tool that measures the existence and performance of key national pharmaceutical sector structures and processes. Its standardized methodology has been developed and refined through several waves of implementation: 2003 WHO Level I surveys, 2008 Medicines Transparency Alliance (MeTA) pharmaceutical sector scans, 2011 WHO Pharmaceutical Sector Country Profiles.  

WHO Level II systematic surveys of health facilities measure key pharmaceutical sector aspects related to medicines availability, quality, prices/affordability, and components of medicines price. They have been used by governments as well as international agencies in many low- and middle-income countries to gather baseline data, and help determine the impacts of interventions aimed at improving access to medicines.      

Dr. Dennis Ross-Degnan has led DPM’s involvement in developing tools and strategies to measure country medicines situations in low and middle income countries since 1985. Dr. Anita Wagner contributed to the analysis and reporting of the 2003 WHO Level I and 2002-2004 Level II surveys. Dr. Catherine Vialle-Valentin developed the pharmaceutical sector scan tools, contributed to the development of the 2011 and 2015 WHO pharmaceutical country profile instruments, and in collaboration with Management Sciences for Health, is supporting work to measure the community impact of Accredited Drug Dispensing Outlets (ADDOs) in Tanzania.

Related Publications

Related Resources

Methodologies and associated tools:

WHO Pharmaceutical Sector Country Profile Questionnaire

WHO Pharmaceutical Sector Country Profile Glossary

MeTA Pharmaceutical Sector Scan

MeTA Data Disclosure Survey

Household & Facility Surveys on Access to and Rational Use of Medicines in Countries

Related Links

WHO Pharmaceutical Sector Country Profiles

Medicines Transparency Alliance

Strengthening Drug Seller Initiatives (SDSI)

Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program

Principal Investigator: Dennis Ross-Degnan

Funders have included: European Community, UK Department for International Development (DFID), World Health Organization, Pan-American Health Organization, USAID through the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Project, and Gates Foundation through the Sustainable Drug Seller Initiatives (SDSI)